Point72 Asset Management, L.P., along with Point72 Capital Advisors, Inc. and Steven A. Cohen, have jointly filed a Schedule 13G, reporting beneficial ownership of 2,290,023 shares of Beta Bionics, Inc. common stock. This constitutes 5.2% of the outstanding shares as of February 20, 2026. The filing indicates that Poin...

Harel Insurance Investments & Financial Services Ltd. has filed a Schedule 13G, reporting beneficial ownership of 1,981,714 Ordinary Shares of Brainsway Ltd., representing 5.2% of the outstanding shares. These shares were acquired on February 16, 2026. The filing clarifies that the majority of shares are held indirectl...

Davidson Kempner Capital Management LP, along with affiliated entities Davidson Kempner Credit Investments LP and Anthony A. Yoseloff, have jointly filed a Schedule 13G, reporting beneficial ownership of ENVIRI Corp common stock. As of February 13, 2026, the reporting persons collectively hold 4,285,800 shares, represe...

Davidson Kempner Capital Management LP, along with affiliated entities Davidson Kempner Credit Investments LP and Anthony A. Yoseloff, have jointly filed a Schedule 13G, reporting beneficial ownership of ENVIRI Corp common stock. As of February 13, 2026, the reporting persons collectively hold 4,285,800 shares, represe...

Harel Insurance Investments & Financial Services Ltd. has filed a Schedule 13G, reporting beneficial ownership of 3,873,305 Ordinary Shares of Gilat Satellite Networks Ltd., representing 5.2% of the outstanding shares as of February 18, 2026. Of these shares, 3,872,201 are held for members of the public through various...

Global Frontier Investments LLC, along with Global Frontier Quantum Opportunity Fund, L.P. and W. Grant Dollens, have jointly filed a Schedule 13G for Infleqtion, Inc. common stock. As of February 23, 2026, Global Frontier Investments LLC holds 25,622,170 shares, representing 11.8% ownership. Global Frontier Quantum Op...

This Schedule 13G filing pertains to LendingTree, Inc. (ticker: TREE) and details the beneficial ownership of its common stock by Megan Greuling, Brent Beason, Lebda Family Holdings, LLC, and the Estate of Douglas R. Lebda. The filing indicates that Megan Greuling beneficially owns 2,547,410 shares, representing 17.59%...

Harel Insurance Investments & Financial Services Ltd. has filed a Schedule 13G, reporting beneficial ownership of 3,873,305 Ordinary Shares of Gilat Satellite Networks Ltd., representing 5.2% of the outstanding shares as of February 18, 2026. Of these shares, 3,872,201 are held for members of the public through various...

Harel Insurance Investments & Financial Services Ltd. has filed a Schedule 13G, reporting beneficial ownership of 1,981,714 Ordinary Shares of Brainsway Ltd., representing 5.2% of the outstanding shares. These shares were acquired on February 16, 2026. The filing clarifies that the majority of shares are held indirectl...

Global Frontier Investments LLC, along with Global Frontier Quantum Opportunity Fund, L.P. and W. Grant Dollens, have jointly filed a Schedule 13G for Infleqtion, Inc. common stock. As of February 23, 2026, Global Frontier Investments LLC holds 25,622,170 shares, representing 11.8% ownership. Global Frontier Quantum Op...

This Schedule 13G filing pertains to LendingTree, Inc. (ticker: TREE) and details the beneficial ownership of its common stock by Megan Greuling, Brent Beason, Lebda Family Holdings, LLC, and the Estate of Douglas R. Lebda. The filing indicates that Megan Greuling beneficially owns 2,547,410 shares, representing 17.59%...

Point72 Asset Management, L.P., along with Point72 Capital Advisors, Inc. and Steven A. Cohen, have jointly filed a Schedule 13G, reporting beneficial ownership of 2,290,023 shares of Beta Bionics, Inc. common stock. This constitutes 5.2% of the outstanding shares as of February 20, 2026. The filing indicates that Poin...

This filing reports that Ryan Taylor, a US citizen, now beneficially owns 753,500 shares of Ascent Solar Technologies, Inc. Common Stock, representing 9.8% of the class. This represents a change from 0.0% ownership previously. Taylor certifies that these shares were not acquired or held for the purpose of influencing t...

Corsair Capital Management, L.P., along with affiliated entities and individuals including Corsair Capital Partners, L.P., Corsair Capital Partners 100, L.P., Corsair Capital Investors, Ltd., Jay R. Petschek, and Steven Major, have collectively reported beneficial ownership of 1,762,650 shares of Cineverse Corp. Common...

Corsair Capital Management, L.P., along with affiliated entities and individuals including Corsair Capital Partners, L.P., Corsair Capital Partners 100, L.P., Corsair Capital Investors, Ltd., Jay R. Petschek, and Steven Major, have collectively reported beneficial ownership of 1,762,650 shares of Cineverse Corp. Common...

Coastlands Capital LP, along with affiliated entities, has acquired a 9.99% stake in Minerva Neurosciences, Inc. The total number of shares beneficially owned by Coastlands Capital LP is 4,563,031. This ownership includes 2,159,245 directly held shares and 2,403,786 shares issuable upon the conversion of Series A Prefe...

Sculptor Capital LP, along with its subsidiaries and affiliates, has filed a Schedule 13G detailing their beneficial ownership of D. Boral Acquisition I Corp. As of February 20, 2026, Sculptor Capital LP and related entities beneficially own 1,750,000 shares of Class A ordinary shares, representing 5.65% of the outstan...

This filing pertains to Tyra Biosciences, Inc. and reports changes in beneficial ownership. Farallon Capital Partners, L.P. and other related entities and individuals, collectively referred to as "Reporting Persons," have acquired shares in Tyra Biosciences, Inc. The filing details the various entities within the Faral...

Vivo Opportunity Fund Holdings, L.P. and its affiliated entities have disclosed a beneficial ownership stake of 9.99% in Immunic, Inc. This stake is primarily composed of shares issuable upon the exercise of pre-funded warrants and regular warrants. The total number of shares issuable to Vivo Opportunity Fund Holdings,...

Intracoastal Capital, LLC, along with individuals Mitchell P. Kopin and Daniel B. Asher, collectively known as the Reporting Persons, have filed a Schedule 13G indicating beneficial ownership of 2,065,885 shares of Liminatus Pharma, Inc. common stock as of February 20, 2026. This represents approximately 4.99% of the c...

Intracoastal Capital, LLC, along with individuals Mitchell P. Kopin and Daniel B. Asher, collectively known as the Reporting Persons, have filed a Schedule 13G indicating beneficial ownership of 2,065,885 shares of Liminatus Pharma, Inc. common stock as of February 20, 2026. This represents approximately 4.99% of the c...

Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, has filed a Schedule 13G regarding their beneficial ownership of NETSTREIT Corp. common stock. As of February 20, 2026, Millennium Management LLC holds 5,246,726 shares, representing 5.4% of the outstanding shares. This owner...

Coastlands Capital LP, along with affiliated entities, has acquired a 9.99% stake in Minerva Neurosciences, Inc. The total number of shares beneficially owned by Coastlands Capital LP is 4,563,031. This ownership includes 2,159,245 directly held shares and 2,403,786 shares issuable upon the conversion of Series A Prefe...

Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, has filed a Schedule 13G regarding their beneficial ownership of NETSTREIT Corp. common stock. As of February 20, 2026, Millennium Management LLC holds 5,246,726 shares, representing 5.4% of the outstanding shares. This owner...

Opaleye Management Inc., along with its affiliates Opaleye, L.P. and James Silverman, has acquired a beneficial ownership of 8.65% in Q32 Bio Inc. The total number of shares held is 1,256,228.00. This filing, made on Schedule 13G, indicates that the shares were acquired and are held without the purpose or effect of cha...